3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Rectal Neoplasms
33
Carcinoma, Non-Small-Cell Lung
19
Squamous Cell Carcinoma of Head and Neck
18
Esophageal Neoplasms
17
Uterine Cervical Neoplasms
11
Nasopharyngeal Carcinoma
11
Head and Neck Neoplasms
11
Pancreatic Neoplasms
9
Oropharyngeal Neoplasms
8
Esophageal Squamous Cell Carcinoma
6
Carcinoma, Squamous Cell
6
Stomach Neoplasms
4
Neoplasms
4
Mouth Neoplasms
4
Glioblastoma
4
Colorectal Neoplasms
4
Carcinoma
4
Adenocarcinoma
4
Urinary Bladder Neoplasms
3
Pathologic Complete Response
3
Hypopharyngeal Neoplasms
3
Thymoma
2
Resectable Esophageal Cancer
2
Neoplasms by Site
2
Nasopharyngeal Neoplasms
2
NSCLC
2
Lymphoma
2
Lung Neoplasms
2
Locally Advanced Malignant Neoplasm
2
Laryngeal Neoplasms
2
Interventions
Microscopy, Confocal
2
Indocyanine Green
2
Everolimus
2
varlilumab
1
Ultrasonography
1
Sunitinib
1
Simvastatin
1
Radiosurgery
1
Palliative Care
1
Neoadjuvant Therapy
1
Narrow Band Imaging
1
Interferon alpha-2
1
IFL protocol
1
Gastrectomy
1
Folfox protocol
1
Endoscopic Mucosal Resection
1
Drug Delivery Systems
1
Drug Combinations
1
Dermoscopy
1
Chemoradiotherapy
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Margins of Excision
×
Chemoradiotherapy
×
Clear all
NCT04389086
2022-09-06
PelvEx II
Catharina Ziekenhuis Eindhoven
Phase 3
Recruiting
364 enrolled